ChemoMetec A/S (FRA:CHY)
Germany
· Delayed Price · Currency is EUR 99.65
-1.25 (-1.24%)
At close: Dec 5, 2025
ChemoMetec Income Statement
Financials in millions DKK. Fiscal year is July - June.
Millions DKK. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 495.57 | 407.35 | 442.27 | 427.16 | 281.13 | Upgrade
|
| Other Revenue | - | 0.52 | 2.13 | 1.23 | - | Upgrade
|
| Revenue | 495.57 | 407.87 | 444.4 | 428.39 | 281.13 | Upgrade
|
| Revenue Growth (YoY) | 21.50% | -8.22% | 3.74% | 52.38% | 31.31% | Upgrade
|
| Cost of Revenue | 30.06 | 40.28 | 32.9 | 44.14 | 27.78 | Upgrade
|
| Gross Profit | 465.51 | 367.6 | 411.5 | 384.25 | 253.34 | Upgrade
|
| Selling, General & Admin | 207.46 | 181.42 | 160.47 | 161.36 | 117.71 | Upgrade
|
| Operating Expenses | 228.99 | 198.63 | 180.94 | 181.4 | 137.32 | Upgrade
|
| Operating Income | 236.52 | 168.97 | 230.56 | 202.85 | 116.02 | Upgrade
|
| Interest Expense | -0.63 | -0.18 | -1.09 | -1.52 | -0.92 | Upgrade
|
| Interest & Investment Income | 5.9 | 8.08 | 2.46 | 0.01 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.78 | -0.27 | -1.57 | 1.87 | -2.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | 240.01 | 176.59 | 230.36 | 203.22 | 112.73 | Upgrade
|
| Pretax Income | 240.01 | 176.59 | 230.36 | 203.22 | 112.73 | Upgrade
|
| Income Tax Expense | 53.61 | 40.3 | 51.69 | 43.75 | 24.38 | Upgrade
|
| Net Income | 186.41 | 136.28 | 178.67 | 159.47 | 88.35 | Upgrade
|
| Net Income to Common | 186.41 | 136.28 | 178.67 | 159.47 | 88.35 | Upgrade
|
| Net Income Growth | 36.78% | -23.72% | 12.04% | 80.49% | 49.34% | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 3.23% | Upgrade
|
| EPS (Basic) | 10.71 | 7.83 | 10.27 | 9.16 | 5.08 | Upgrade
|
| EPS (Diluted) | 10.71 | 7.83 | 10.27 | 9.16 | 5.08 | Upgrade
|
| EPS Growth | 36.78% | -23.73% | 12.08% | 80.42% | 44.66% | Upgrade
|
| Free Cash Flow | 177.58 | 108.06 | 132.97 | 137.76 | 96.65 | Upgrade
|
| Free Cash Flow Per Share | 10.20 | 6.21 | 7.64 | 7.92 | 5.55 | Upgrade
|
| Dividend Per Share | 7.000 | 4.000 | 6.000 | - | 4.000 | Upgrade
|
| Dividend Growth | 75.00% | -33.33% | - | - | 166.67% | Upgrade
|
| Gross Margin | 93.93% | 90.13% | 92.60% | 89.70% | 90.12% | Upgrade
|
| Operating Margin | 47.73% | 41.43% | 51.88% | 47.35% | 41.27% | Upgrade
|
| Profit Margin | 37.61% | 33.41% | 40.20% | 37.23% | 31.43% | Upgrade
|
| Free Cash Flow Margin | 35.83% | 26.49% | 29.92% | 32.16% | 34.38% | Upgrade
|
| EBITDA | 247.68 | 178.78 | 244.49 | 216.65 | 129.01 | Upgrade
|
| EBITDA Margin | 49.98% | 43.83% | 55.02% | 50.57% | 45.89% | Upgrade
|
| D&A For EBITDA | 11.17 | 9.82 | 13.93 | 13.8 | 12.98 | Upgrade
|
| EBIT | 236.52 | 168.97 | 230.56 | 202.85 | 116.02 | Upgrade
|
| EBIT Margin | 47.73% | 41.43% | 51.88% | 47.35% | 41.27% | Upgrade
|
| Effective Tax Rate | 22.34% | 22.82% | 22.44% | 21.53% | 21.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.